• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
AIDS-Related Kaposi's Sarcoma - Pipeline Review, Q3 2011 - Product Image

AIDS-Related Kaposi's Sarcoma - Pipeline Review, Q3 2011

  • Published: July 2011
  • 63 pages
  • Global Markets Direct

AIDS-Related Kaposi's Sarcoma - Pipeline Review, Q3 2011

Summary

Global Markets Direct’s, 'AIDS-Related Kaposi's Sarcoma - Pipeline Review, Q3 2011', provides an overview of the AIDS-Related Kaposi's Sarcoma therapeutic pipeline. This report provides information on the therapeutic development for AIDS-Related Kaposi's Sarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for AIDS-Related Kaposi's Sarcoma. 'AIDS-Related Kaposi's Sarcoma - Pipeline Review, Q3 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note-: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for AIDS-Related Kaposi's Sarcoma.
- A review of the AIDS-Related READ MORE >



List of Tables
List of Figures
Introduction
AIDS-Related Kaposi's Sarcoma Overview
Therapeutics Development
AIDS-Related Kaposi's Sarcoma Therapeutics under Development by Companies
AIDS-Related Kaposi's Sarcoma Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Mid Clinical Stage Products
Early Clinical Stage Products
Pre-Clinical Stage Products
AIDS-Related Kaposi's Sarcoma Therapeutics - Products under Development by Companies
AIDS-Related Kaposi's Sarcoma Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in AIDS-Related Kaposi's Sarcoma Therapeutics Development
AIDS-Related Kaposi's Sarcoma - Therapeutics Assessment
Late Stage Drug Profiles
AIDS-Related Kaposi's Sarcoma Therapeutics – Drug Profile Updates
AIDS-Related Kaposi's Sarcoma Therapeutics - Discontinued Products
Appendix
Methodology
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for AIDS-Related Kaposi's Sarcoma, Q3 2011
Products under Development for AIDS-Related Kaposi's Sarcoma – Comparative Analysis, Q3 2011
Number of Products under Development by Companies, Q3 2011
Number of Products under Investigation by Universities/Institutes, Q3 2011
Comparative Analysis by Late Stage Development, Q3 2011
Comparative Analysis by Mid Clinical Stage Development, Q3 2011
Comparative Analysis by Early Clinical Stage Development, Q3 2011
Comparative Analysis by Pre-Clinical Stage Development, Q3 2011
Products under Development by Companies, Q3 2011
Products under Investigation by Universities/Institutes, Q3 2011
Products under Investigation by Universities/Institutes, Q3 2011
Aphios Corporation, 2011
PTC Therapeutics, Inc., 2011
Assessment by Monotherapy Products, Q3 2011
Assessment by Combination Products
Assessment by Stage and Route of Administration, Q3 2011
Assessment by Molecule Type, Q3 2011
AIDS-Related Kaposi's Sarcoma Therapeutics – Drug Profile Updates
Discontinued Products

List of Figures
Number of Products under Development for AIDS-Related Kaposi's Sarcoma, Q3 2011
Products under Development for AIDS-Related Kaposi's Sarcoma – Comparative Analysis, Q3 2011
Products under Development by Companies, Q3 2011
Products under Investigation by Universities/Institutes, Q3 2011
Late Stage Products, Q3 2011
Mid Clinical Stage Products, Q3 2011
Early Clinical Stage Products, Q3 2011
Pre-Clinical Stage Products, Q3 2011
Assessment by Monotherapy Products, Q3 2011
Assessment by Combination Products, Q3 2011
Assessment by Route of Administration, Q3 2011
Assessment by Stage and Route of Administration, Q3 2011
Assessment by Molecule Type, Q3 2011
Assessment by Stage and Molecule Type, Q3 2011

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos